Treatment strategies for endometriosis

Bibliography

• Barbieri RL. Endometriosis 1990 current treatment approaches. Drugs 1990;39(4):502-10
   PubMed Web of Science ®Google Scholar
• Hemmings R, Rivard M, Olive D, et al. Evaluation of risk factors associated with endometriosis. Fertil Steril 2004;81:1513-21
   PubMed Web of Science ®Google Scholar
• Coxhead D, Thomas EJ. Familial inheritance of endometriosis in a British population. A case control study. J Obstet Gynaecol 1993;13:42-4
   Google Scholar
• Zondervan KT, Cardon LR, Kennedy SH. The genetic basis of endometriosis. Curr Opin Obstet Gynecol 2001;13:309-14
   PubMed Web of Science ®Google Scholar
• Vercellini P, Trespidi L, De Giorgi O, et al. Endometriosis and pelvic pain: relation to disease stage and location. Fertil Steril 1996;65:299-304
   PubMed Web of Science ®Google Scholar
• The American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-5
   PubMed Web of Science ®Google Scholar
• Matorras R, Rodriguez F, Pijoan JI, et al. Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis. Fertil Steril 2001;76:923-8
   PubMedGoogle Scholar
• Hemmings R, Falcone T. Endometriosis. In: Falcone T, Hurd WW, editors. Clinical Reproductive Medicine and Surgery. Philadelphia: Mosby Elsevier Publishers; 2007. p. 729-45
   Google Scholar
• Harada T, Kaponis A, Iwabe T, et al. Apoptosis in human endometrium and endometriosis. Hum Reprod 2004;19:29-38
   Google Scholar
• Kokorine I, Nisolle M, Donez J, et al. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 1997;68:246-51
   PubMed Web of Science ®Google Scholar
• ASRM 2006. American Society of Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2006;86(Suppl 4): S18-27
   PubMed Web of Science ®Google Scholar
• Osten KG, Igarashi TM, Yeaman GR, Bruner-Trankl. Steroid and cytokine regulation of matrix metalloproteinases and the pathophysiology of endometriosis. Gynecol Obstet Invest 2003;21:155-63
   Google Scholar
• Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-90
   PubMed Web of Science ®Google Scholar
• Oosterlynck DJ, Cornillie FJ, Waer M, et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Mueller MD, Taylor R. Immunobiology of endometriosis. Fertil Steril 2001;75:1-10
   PubMed Web of Science ®Google Scholar
• Stegmann BJ, Sinaii N, Liu S, et al. Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women. Fertil Steril 2007
   Google Scholar
• Fedele L, Parazzini F, Bianchi S, et al. Stage and localization of pelvic endometriosis and pain. Fertil Steril 1990;53:155-8
   PubMed Web of Science ®Google Scholar
• Donnez J, Gillet N, Nisolle M, et al. Peritoneal endometriosis and “endometriotic” nodules of the rectovaginal septum are two different entities. Fertil Steril 1996;66:362-8
   PubMed Web of Science ®Google Scholar
• Tokushiqe N, Markham R, Russell P, Fraser I. Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis. Fertil Steril 2007;88:795-803
   PubMedGoogle Scholar
• Riley JL, Robinson ME, Wise EA, Price DD. A meta-analytic review of pain perception across the menstrual cycle. Pain 1999;81:225-35
   PubMed Web of Science ®Google Scholar
• Porpora MG, Koninckx PR, Piazze J, et al. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc 1999;6:429-34
   PubMedGoogle Scholar
• Gupta S, Agarwal A, Sekhon L, et al. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol 2006;58
   Google Scholar
• Fujii J, Icuhi Y, Okada F. Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reprod Biol Endocrinol 2005;3:43-53
   PubMed Web of Science ®Google Scholar
• Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003;79:829-43
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol 2006;18:325-32
   PubMed Web of Science ®Google Scholar
• Rice VM. Conventional Medical therapies for endometriosis. Ann NY Acad Sci 2002;955:343-52; Discussion: 389-93, 396-406
   PubMed Web of Science ®Google Scholar
• Marana R, Caruana P, Muzii L, et al. Operative laparoscopy for ovarian cysts. Excision vs. Aspiration. J Reprod Med 1996;41:279-82
   PubMedGoogle Scholar
• Jacobson TZ, Barlow DH, Garry R, Koninckx P. Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2001;(4):CD001300. DOI: 10.1002/14651858.CD001300
   Google Scholar
• Sutton CJ, Ewen SP, Whitelaw N, Haines P. Prospective randomized, double-blind controlled trial of laser laparoscopy I the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril 1994;62:696-70
   PubMed Web of Science ®Google Scholar
• Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 2004;16:299-303
   PubMed Web of Science ®Google Scholar
• Zullo F, Palomba S, Zupi E, et al. Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis ho were treated with laparoscopic conservative surgery: a 1-year prospective randomized double-blind controlled trial. Am J Obstet Gynecol 2003;189:5-10
   PubMedGoogle Scholar
• Kennedy S, Berggvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;20(10):2698-704
   PubMed Web of Science ®Google Scholar
• Vercellini P, Aimi G, Busacca MA, et al. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril 2003;80:310-9
   PubMed Web of Science ®Google Scholar
• Proctor ML, Latthe PM, Farquhar CM, et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2005;(4):CD001896. DOI: 10.1002/14651858.CD001896.pub2
   Google Scholar
• Tulandi T, Al-Took S. Reproductive outcomes after treatment of mild endometriosis with laparoscopic excision and electrocoagulation. Fertil Steril 1998;69(2):229-31
   PubMedGoogle Scholar
• Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev 2004;(3):CD003678. DOI: 10.1002/14651858.CD003678.pub2
   Google Scholar
• Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005;(4):CD004753. DOI: 10.1002/14651858.CD004753.pub2.
   PubMedGoogle Scholar
• Marioribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003;(4):CD001751. DOI: 10.1002/14651858.CD001751.
   Google Scholar
• Dawood MY. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand 1986;138(Suppl):7-10
   Google Scholar
• Juni P, Nartey L, Reichenbac S, et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-9
   PubMed Web of Science ®Google Scholar
• Davis L, Kennedy SS, Moore J, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007;(3):CD001019. DOI: 10.1002/14651858.CD001019.pub2
   PubMed Web of Science ®Google Scholar
• Kubi-Garfias C. Modulatory action of 5-reduced androgens and progesteogens on the excitability of CNS and smooth muscle. J Steroid Biochem 1987;27:631-4
   PubMedGoogle Scholar
• Abou-Setta AM, Al-Inany HG, Farquhar CM. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2006;(4):CD005072. DOI: 10.1002/14651858.CD005072.pub2
   Google Scholar
• Crosignani PG, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod 2006;12(2):179-89
   Google Scholar
• Vercellini P, Frontino G, Degiorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2004;80(2):305-9
   Google Scholar
• Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75(3):485-8
   PubMed Web of Science ®Google Scholar
• Schlaff WD, Carson SA, Luciano A, et al. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 2006;85(2):314-25
   PubMed Web of Science ®Google Scholar
• Meresman GF, Bilotas MA, Lombardi E, et al. Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 2003;18(9):1767-71
   PubMed Web of Science ®Google Scholar
• Meresman GF, Bilotas M, Buquet RA, et al. Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis. Fertil Steril 2003;80(Suppl 2):702-7
   PubMed Web of Science ®Google Scholar
• Batzer FR. GnRH analogs: options for endometriosis-associated treatment. J Min Invas Gynecol 2006;13:539-45
   PubMed Web of Science ®Google Scholar
• Henzi MR, Corson SL, Moghissi K, et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988;318(8):485-9
   PubMedGoogle Scholar
• Ling FW. Randomized controlled trial of leuprolide inpatients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol 1999;93:51-8
   PubMed Web of Science ®Google Scholar
• Sagsveen M, Farmer JE, Prentice A, Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003;(4):CD001297. DOI: 10.1002/14651858.CD001297
   PubMedGoogle Scholar
• Hornstein MD, Surrey ES, Weisbergy GW, Casino LA. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study group. Obstet Gynecol 1998;91:16-24
   PubMed Web of Science ®Google Scholar
• Prentice A, Deary AJ, Blande. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2000;(2):CD002122. DOI: 10.1002/14651858.CD002122
   PubMedGoogle Scholar
• Ferrero S, Abbamonte LH, Anserini P, et al. Future perspectives in the medical treatment of endometriosis. Obstet Gynecol Survey 2005;60(12)817-26
   PubMed Web of Science ®Google Scholar
• Cobellis L, Razzi S, Fava A, et al. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dysparunia associated with endometriosis. Fertil Steril 2004;82:239-40
   PubMed Web of Science ®Google Scholar
• Ozawa Y, Murakami T, Yerada Y, et al. Management of the pain associated with endometriosis: an update of the painful problems. J Exp Med 2006;210:175-88
   Google Scholar
• Razzi S, Luisi S, Calonaci F, et al. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007;88(4):789-94
   PubMed Web of Science ®Google Scholar
• Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril 2006;85(5):1307-18
   PubMed Web of Science ®Google Scholar
• Sebastian S, Bulun SE. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project. J Clin Endocrinol Infertil 2001;86:4600-2
   PubMed Web of Science ®Google Scholar
• Dejong PC, Van De Ven J, Nortier HW, et al. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation armoatase inhibitor vorozole. Cancer Res 1997;57:2109-11
   PubMedGoogle Scholar
• Nobel LS, Takayama K, Putman JM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrin Metab 1997;82:600-6
   PubMedGoogle Scholar
• Nobel LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrin Metab 1996;81:174-9
   PubMedGoogle Scholar
• Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase P450 promoter II activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of SF-1 and COUP-TF to the same cis-acting element. Mol Endocrinol 1999;13:239-53
   PubMed Web of Science ®Google Scholar
• Wu M, Want C, Lin C, et al. Distinct regulation of cyclooxygenase-2 by interleukin1 (beta) in normal and endometriotic stromal cells. J Clin Endocrinol Metab 2005;90:286-95
   PubMed Web of Science ®Google Scholar
• Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001;16:561-6
   PubMed Web of Science ®Google Scholar
• Bulun SE, Zeitoun K, Takayama K, et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer 1999;6:293-301
   PubMed Web of Science ®Google Scholar
• Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1999;69:709-13
   Google Scholar
• Kitawaki J, Kusuki I, Koshiba H, et al. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999;72:1100-6
   PubMed Web of Science ®Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, et al. Anastrozole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84:300-4
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305-9
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002;77:776-80
   PubMed Web of Science ®Google Scholar
• Cortinez A, De Carvalho I, Vantman D, et al. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimuation in ovulatory infertile patients. Fertil Steril 2005;83:110-5
   PubMed Web of Science ®Google Scholar
• Fisher SA, Reid RL, Van Vugt DA, Casper FR. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on the ovulatory function in normal women. Fertil Steril 2002;78:280-5
   PubMed Web of Science ®Google Scholar
• Goswami SK, Das T, Chattopadhyay R, et al. A randomized single-blind controlled trial of letrozole as a low cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 2004;19:2031-5
   PubMed Web of Science ®Google Scholar
• Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85(6):1761-5
   PubMed Web of Science ®Google Scholar
• Buzdar AU. The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial: an update. Clin Breast Cancer 2004;5(Suppl 1):S6-12
   Google Scholar
• Soysal S, Soysal M, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004;19:160-7
   PubMed Web of Science ®Google Scholar
• Mousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007;109(6):1421-3
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004;81:290-6
   PubMed Web of Science ®Google Scholar
• Shippen ER, West WJ Jr. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril 2004;81:1395-8
   PubMed Web of Science ®Google Scholar
• Jiang J, Wu RF, Wantk ZH, et al. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro. Fertil Steril 2002;77:995-1000
   PubMedGoogle Scholar
• Kettel LM, Murphy AA, Mortola JF, et al. Endocrine responses to long-term administration of the antiprogesterone RU486 in patens with pelvic endometriosis. Fertil Steril 1991;56:402-7
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Mortola JF, et al. Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod 1994;9(Suppl 1):116-20
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Morales AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996;65:23-8
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Mortola JF, et al. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). Am J Obstet Gynecol 1998;178:1151-6
   PubMed Web of Science ®Google Scholar
• Stoeckermann K, Hegele-Hartung C, Chalisz K. Effects of the progesterone antagonist Onapristone (ZK 98 299) and ZK (136 799) on surgically induced endometriosis in intact rats. Hum Reprod 1995;10:3264-71
   PubMedGoogle Scholar
• Tjaden B, Galetto D, Woodruff JD, et al. Time-related effects of RU486 treatment in experimentally induced endometriosis in the rat. Fertil Steril 1993;59:437-40
   PubMed Web of Science ®Google Scholar
• Demanno D, Elger W, Garg R, et al. Asoprisnil (J867): a selective progesterone receptor modulator for gynaecological therapy. Steroids 2003;68:1019-32
   PubMed Web of Science ®Google Scholar
• Chwalisz K, Mattia-Goldberg C, Lee M, et al. Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) Asoprisnil. Fertil Steril 2004;82(Suppl 2):S83-4
   Google Scholar
• Harris HA, Bruner-Tran KL, Zhang X, et al. A selective estrogen receptor-β agonists causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005;20(4):936-41
   PubMed Web of Science ®Google Scholar
• Harris HA, Albert LM, Leathurby Y, et al. Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology 2003;144:4241-9
   PubMed Web of Science ®Google Scholar
• Keenan JA, Williams-Boyce PK, Massey PJ, et al. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loroxibine and levamisole. Fertil Steril 1999;72:135-41
   PubMed Web of Science ®Google Scholar
• Balawy SZ, Etman A, Cuenca V, et al. effect of interferon alpha-22b on endometrioma cells in vitro. Obstet Gynecol 2001;98:417-20
   PubMedGoogle Scholar
• Ingelmo JM, Quereda F, Acien P. Intraperitoneal and subcutaneous treatment of enxperimental enodmetriosis with recombinant human interferon-alpha-2b in a murine model. Fertil Steril 1999;71:907-11
   PubMed Web of Science ®Google Scholar
• Acien P, Quereda F, Campos A, et al. Use of intraperitoneal interferon alpha-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial. Fertil Steril 2002;78:705-11
   PubMed Web of Science ®Google Scholar
• Barrier BF, Bates GW, Leland MM, et al. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil Steril 2004;81(Suppl 1):775-9
   PubMed Web of Science ®Google Scholar
• D'Antonio M, Martinelli F, Peano S, et al. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. J Repro Immun 2000;48:81-98
   PubMed Web of Science ®Google Scholar
• Falconer H, Mweda JM, Chai DC, et al. Treatment with TNF antibody c5N reduces the extent of induced endometriosis in the baboon. Fertil Steril (2004);82(Suppl 2):S54-5
   Google Scholar
• Shakiba K, Falcone T. Tumour necrosis factor-α blockers: potential limitations in the management of advanced endometriosis? A case report. Hum Reprod 2006;21(9):2417-20
   PubMedGoogle Scholar
• American Society for Reproductive Medicine: Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1997;67:817
   PubMed Web of Science ®Google Scholar